Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Editorial

Outliving colorectal cancer

Alan Barkun and Ken Flegel
CMAJ September 11, 2007 177 (6) 545; DOI: https://doi.org/10.1503/cmaj.071118
Alan Barkun MDCM MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Flegel MDCM MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading
  • © 2007 Canadian Medical Association

In Canada in 2007, about 20 460 new cases of colorectal cancer will be diagnosed and 8700 people will die from this disease.1 About half would live if this country had a more robust and coherent approach to early detection and treatment. Unlike lung cancer, another big killer, colon cancer is easy to detect in its early stage, when it is most often premalignant. And unlike early detection in breast and prostate cancer, early detection in colorectal cancer, especially in the precancerous adenoma stage, routinely leads to excision and cure. Furthermore, if colorectal cancer is detected early, the mortality is low, with 90% of patients surviving 5 years.

Most lesions are detected in asymptomatic patients screened by manoeuvres such as fecal occult blood testing, sigmoidoscopy or colonoscopy.2 A single exposure to sigmoidoscopy reduces the risk of fatal distal colorectal cancer by about 60% over 10 years and reduces the risk of colon cancer by 44% over 6 years.3 In addition, the incremental cost-effectiveness ratio for each of the currently accepted modalities for colorectal cancer screening is consistently less than $50 000 per life-year saved — below that for cervical, breast and prostate cancers.4

With the anticipated introduction of new diagnostic technologies, such as computed tomography colography, stool DNA testing and wireless videocapsule examination of the colon, patients may, in the future, be able to undergo screening with minimal disruption, perhaps even in their home or workplace. But in the foreseeable future, these methods will not supplant the need for conventional colonoscopy to address true-and false-positive results of colonic pathology by other screening methods. Nor will these new technologies address barriers to screening.

The proportion of patients screened for colorectal cancer has been extraordinarily low in Canada.5 In this issue, we highlight the results of a 2003 survey in which only 23.5% people at average risk reported receiving screening.6 By contrast, in the United States in 2000, where a concerted effort was made to introduce national screening, 62.9% of people at average risk underwent screening.7 National screening programs are also under way in the United Kingdom and Europe, but Canada continues to lag, with only a few provincial initiatives (see page 593).

A concerted effort to combat this cancer must begin with the adoption of colorectal screening as a national health priority. Canada's program must include adequate resources as well as patient and physician education. Informing Canadians of the risks of colorectal cancer will likely prompt them to request screening. But physicians have a key role. At present, the most common reason for not undergoing screening is that it was not recommended by the treating physician. (Practitioners should take note that over half of all malpractice actions against primary care physicians with regard to gastrointestinal diseases result from a delay in colorectal cancer diagnosis.)

Until there is an active national program, individual physicians must take the lead. Although several professional societies and foundations are poised and willing to help, physicians must first address their own ignorance and reticence and accept their duty to begin informing and persuading their patients to be screened.

We do have the means and the opportunity to stop this killer. We lack only the education and the national will; it is abundantly clear that to stay the present course of inaction will continue to cost thousands of lives.

REFERENCES

  1. 1.↵
    Canadian cancer statistics 2007. Toronto: Canadian Cancer Society/National Cancer Institute of Canada; 2007. p. 13. Available: http://129.33.170.32/ccs/internet/standard/0,3182,3172_14279__langId-en,00.html (accessed 2007 Aug 2).
  2. 2.↵
    Ferraris R, Senore C, Fracchia M, et al. Predictive value of rectal bleeding for distal colonic neoplastic lesions in a screened population. Eur J Cancer 2004;40:245-52.
    OpenUrlCrossRefPubMed
  3. 3.↵
    Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy: a case–control study of 32 702 veterans. Ann Intern Med 1995;123: 904-10.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Barkun AN, Jobin G, Cousineau G, et al. The Quebec Association of Gastroenterology position paper on colorectal cancer screening—2003. Can J Gastroenterol 2004;18:509-19.
    OpenUrlPubMed
  5. 5.↵
    Rabeneck L, Paszat LF. A population-based estimate of the extent of colorectal cancer screening in Ontario. Am J Gastroenterol 2004;99:1141-4.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Zarychanski R, Chen Y, Bernstein CN, et al. Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour. CMAJ 2007;177: 593-7.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Peterson NB, Murff HJ, Ness RM, et al. Colorectal cancer screening among men and women in the United States. J Womens Health (Larchmt) 2007;16:57-65.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 177 (6)
CMAJ
Vol. 177, Issue 6
11 Sep 2007
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Outliving colorectal cancer
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Outliving colorectal cancer
Alan Barkun, Ken Flegel
CMAJ Sep 2007, 177 (6) 545; DOI: 10.1503/cmaj.071118

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Outliving colorectal cancer
Alan Barkun, Ken Flegel
CMAJ Sep 2007, 177 (6) 545; DOI: 10.1503/cmaj.071118
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • REFERENCES
  • Responses
  • Metrics
  • PDF

Related Articles

  • Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour
  • Highlights of this issue
  • Cross-Canada colorectal cancer screening programs remain elusive
  • PubMed
  • Google Scholar

Cited By...

  • Rates of colorectal cancer screening
  • Colorectal cancer screening
  • Colorectal cancer screening
  • Google Scholar

More in this TOC Section

  • Regard sur la santé des personnes noires et le racisme anti-Noirs dans les systèmes de santé au Canada
  • A focus on access to health care in Canada
  • L’avenir de la médecine est ici et vous en êtes la trame narrative
Show more Éditorial

Similar Articles

Collections

  • Topics
    • Cancer & oncology
    • Screening & diagnostic tests

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire